How often it happens The rates vary by trial and population: 2,3 TRIUMPH-4 (obesity with knee osteoarthritis): 8.8% on 9 mg, 20.9% on 12 mg, 0.7% on placebo TRANSCEND-T2D-1 (type 2 diabetes): 4.5% on 4 mg, 2.3% on 9 mg, 4.4% on 12 mg, 0% on placebo Phase 2 trial (Jastreboff 2023): not reported The TRIUMPH-4 numbers are markedly higher than those of TRANSCEND-T2D-1
People following vegetarian or vegan diets may also need a more reliable source, since B12 is primarily found in animal products
Copper toxicity from skincare products has never been reported in clinical literature
Get Started Backed by Science
Our main concern is the low-touch care model that limits direct, in-person interaction between the patient and the provider
Two years ago, Jennifer Silver, 34, a dentist in Alberta, Canada, began taking a GLP-1 agonist medication to lose weight